Nimesulida Generis (Nimesulide)

Nimesulide, the active ingredient in Nimesulida Generis, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It provides analgesic, anti‑inflammatory and antipyretic effects for adults experiencing pain, inflammation, osteoarthritis or dysmenorrhea.

GNH USA supplies Nimesulida Generis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing, regulatory documentation and logistics support for bulk and unit‑dose requirements. The company adheres to EU GMP standards and offers flexible packaging options to meet diverse market needs.

Nimesulide is an NSAID that reduces inflammation and pain by targeting cyclo‑oxygenase pathways. - Pain: provides analgesic relief for acute and chronic pain conditions. - Inflammation: diminishes inflammatory response in musculoskeletal disorders. - Osteoarthritis: improves joint function and reduces pain associated with osteoarthritis. - Dysmenorrhea: alleviates menstrual pain and associated discomfort.

Nimesulide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Skin rash or pruritus. - Elevated liver enzymes detected in routine tests.

Serious or Rare Side Effects: - Hepatotoxicity: severe liver injury or failure. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Gastrointestinal ulceration or bleeding. - Acute renal impairment or failure. - Blood dyscrasias such as agranulocytosis. - Anaphylactic or severe allergic reactions.

When prescribing Nimesulide, clinicians should observe several safety precautions to minimize risk. - Assess liver function: obtain baseline hepatic enzymes before treatment. - Avoid in patients with known hypersensitivity to NSAIDs or sulfonamides. - Use the lowest effective dose for the shortest duration required. - Monitor renal function: especially in elderly or dehydrated individuals. - Caution with concomitant anticoagulants or other COX‑2 inhibitors. - Store at room temperature: keep in the original pack, protect from moisture.

Nimesulide can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Concurrent use with other NSAIDs or COX‑2 inhibitors: increased risk of gastrointestinal toxicity. - Combination with anticoagulants (e.g., warfarin): heightened bleeding risk. - Co‑administration with hepatotoxic drugs (e.g., isoniazid, methotrexate): potential liver injury.

Moderate Interactions (Monitor Closely): - Use with antihypertensive agents: may reduce blood‑pressure‑lowering effect. - Concomitant diuretics: possible decline in renal function. - Lithium therapy: nimesulide may raise serum lithium concentrations.